Ganguly Koelina, Cox Jesse L, Ghersi Dario, Grandgenett Paul M, Hollingsworth Michael A, Jain Maneesh, Kumar Sushil, Batra Surinder K
Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, Nebraska.
Gastroenterology. 2022 Jun;162(7):2032-2046.e12. doi: 10.1053/j.gastro.2022.02.032. Epub 2022 Feb 24.
BACKGROUND & AIMS: Secreted mucin 5AC (MUC5AC) promotes pancreatic cancer (PC) progression and chemoresistance, suggesting its clinical association with poor prognosis. RNA sequencing analysis from the autochthonous pancreatic tumors showed a significant stromal alteration on genetic ablation of Muc5ac. Previously, depletion or targeting the stromal fibroblasts showed an ambiguous effect on PC pathogenesis. Hence, identifying the molecular players and mechanisms driving fibroblast heterogeneity is critical for improved clinical outcomes.
Autochthonous murine models of PC (Kras, Pdx1-Cre [KC] and Kras, Pdx1-Cre, Muc5ac [KCM]) and co-implanted allografts of murine PC cell lines (Muc5ac wild-type and CRISPR/Cas knockout) with adipose-derived mesenchymal stem cells (AD-MSCs) were used to assess the role of Muc5ac in stromal heterogeneity. Proliferation, migration, and surface expression of cell-adhesion markers on AD-MSCs were measured using live-cell imaging and flow cytometry. MUC5AC-interactome was investigated using mass-spectrometry and enzyme-linked immunosorbent assay.
The KCM tumors showed a significant decrease in the expression of α-smooth muscle actin and fibronectin compared with histology-matched KC tumors. Our study showed that MUC5AC, carrying tumor secretome, gets enriched in the adipose tissues of tumor-bearing mice and patients with PC, promoting CD44/CD29 (integrin-β1) clustering that leads to Rac1 activation and migration of AD-MSCs. Furthermore, treatment with KC-derived serum enhanced proliferation and migration of AD-MSCs, which was abolished on Muc5ac-depletion or pharmacologic inhibition of CXCR2 and Rac1, respectively. The AD-MSCs significantly contribute toward α-smooth muscle actin-positive cancer-associated fibroblasts population in Muc5ac-dependent manner, as suggested by autochthonous tumors, co-implantation xenografts, and patient tumors.
MUC5AC, secreted during PC progression, enriches in adipose and enhances the mobilization of AD-MSCs. On recruitment to pancreatic tumors, AD-MSCs proliferate and contribute towards stromal heterogeneity.
分泌型黏蛋白5AC(MUC5AC)促进胰腺癌(PC)进展和化疗耐药,提示其与预后不良存在临床关联。对原位胰腺肿瘤的RNA测序分析显示,Muc5ac基因消融后基质有显著改变。此前,对基质成纤维细胞的消耗或靶向对PC发病机制的影响尚不明确。因此,确定驱动成纤维细胞异质性的分子因素和机制对于改善临床结局至关重要。
利用PC的原位小鼠模型(Kras、Pdx1-Cre [KC]和Kras、Pdx1-Cre、Muc5ac [KCM])以及将小鼠PC细胞系(Muc5ac野生型和CRISPR/Cas敲除型)与脂肪来源间充质干细胞(AD-MSCs)共植入的同种异体移植模型,评估Muc5ac在基质异质性中的作用。使用活细胞成像和流式细胞术测量AD-MSCs上细胞黏附标志物的增殖、迁移和表面表达。利用质谱和酶联免疫吸附测定法研究MUC5AC相互作用组。
与组织学匹配的KC肿瘤相比,KCM肿瘤中α平滑肌肌动蛋白和纤连蛋白的表达显著降低。我们的研究表明,携带肿瘤分泌组的MUC5AC在荷瘤小鼠和PC患者的脂肪组织中富集,促进CD44/CD29(整合素-β1)聚集,导致Rac1激活和AD-MSCs迁移。此外,用KC来源的血清处理可增强AD-MSCs的增殖和迁移,而分别对Muc5ac进行消耗或对CXCR2和Rac1进行药理抑制可消除这种作用。原位肿瘤、共植入异种移植和患者肿瘤表明,AD-MSCs以Muc5ac依赖的方式对α平滑肌肌动蛋白阳性的癌症相关成纤维细胞群体有显著贡献。
PC进展过程中分泌的MUC5AC在脂肪中富集并增强AD-MSCs的动员。募集到胰腺肿瘤后,AD-MSCs增殖并促进基质异质性。